Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for IP3(145) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IP3(145) participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 1 | 0 | 5 | 5 | 3 | 3 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
IP3metabolism | 32 | Network | MIPP, CaMKII, CaM, PKC, IP3-3K, Gq, PLCbeta, 134_dephos, 145_dephos, IP4-system, IHP-system, 1345_dephos, CaRegulation, Othmer-Tang-model |
| This network models an oscillatory calcium response to GPCR mediated PLCbeta activation, alongwith detailed InsP3 metabolism in the neuron. It is similar to the Osc_Ca_IP3metab model (accession 24) except that some enzymes in the InsP3 metabolism network have been modified to have reversible kinetics rather than Michaelis-Menten kinetics. The modified enzymes belong to the groups: IP4-system, IP3-3K, 145_dephos and 134_dephos. Mishra J, Bhalla US. Biophys J. 2002 Sep;83(3):1298-316. | |||
IP3(145) acting as a Molecule in Osc_Ca_IP3metabolism Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| IP3(145) | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 0.2 | 1000 | No | |
| Inositol (145)trisphosphate | ||||||
IP3(145) acting as a Summed Molecule in Osc_Ca_IP3metabolism Network
| Accession Name | Pathway Name | Target | Input |
IP3metabolism Accession No. : 32 | l Pathway No. : 171 | IP3 | IP3(145) |
| Inositol(145)trisphosphate in the cytoplasm. Levels are determined by the IP3-metabolism network | |||
IP3(145) acting as a Substrate for an Enzyme in Osc_Ca_IP3metabolism Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | IP3_3K / ip3-3k | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 1.40001 | 3.0475 | 4 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Johanson et al, JBC 263; 1988 Original Vmax scaled up by 50% to obtain value at 37C, as enzyme assay was done at 30C Km increased from 0.2 to 1.4 as per various other reports (Shears Review, BiochemJ 260; 1989) | ||||||||
| 2 | IP3_3K*1 / ip3-3k*1 | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 1.40004 | 0.76187 | 4.00003 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Sim et al, JBC 265; 1990 | ||||||||
| 3 | IP3_3K* / ip3-3k* | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 1.40001 | 3.0475 | 4 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Communi et al, EMBO J 16; 1997 In absence of CaM binding, activity same as that of non-phosphorylated enzyme | ||||||||
| 4 | IP3_5pase2 / ip3_5pase2 | IP3metabolism Accession No. : 32 | 145_dephos Pathway No. : 166 | 18.0004 | 10.667 | 3.99991 | explicit E-S complex | Substrate IP3(145) Product IP2(14) |
| from Hansen et al, JBC 262, 1987 activity determined from pH curve. Value scaled 1.5 times to obtain activity at 37C as original experiment was performed at 30C | ||||||||
| 5 | IP_5pase1 / ip3_5pase1 | IP3metabolism Accession No. : 32 | 145_dephos Pathway No. : 166 | 3.00001 | 1.1 | 4 | explicit E-S complex | Substrate IP3(145) Product IP2(14) |
| Ins(145)P3 5-phosphatase activity of InsP-5-phosphatase from Hansen et al, JBC 262; 1987 | ||||||||
IP3(145) acting as a Product of an Enzyme in Osc_Ca_IP3metabolism Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PLC-Gq / PLC-Gq | IP3metabolism Accession No. : 32 | PLCbeta Pathway No. : 164 | 5 | 75 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| from Smrcka et al, 1991 Science 251: 804-807 | ||||||||
| 2 | PLC-Ca / PLC-Ca | IP3metabolism Accession No. : 32 | PLCbeta Pathway No. : 164 | 19.8408 | 10 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| From Sternweis et al Phil Trans R Soc Lond 1992, also matched by Homma et al. k1 = 1.5e-5, now 4.2e-6 k2 = 70/sec; now 40/sec k3 = 17.5/sec; now 10/sec Note that the wording in Sternweis et al is ambiguous re the Km. Also Smrcka et al; Science 251, 15.2.1991, pp804-807 | ||||||||
| 3 | PLC-Ca-Gq / PLCb-Ca-Gq | IP3metabolism Accession No. : 32 | PLCbeta Pathway No. : 164 | 4.99994 | 160 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| Km: Sternweis et al, Phil Trans R Soc Lond 1992 Vmax: Smrcka et al, Science 1991 | ||||||||
| 4 | PLC / PLC | IP3metabolism Accession No. : 32 | PLCbeta Pathway No. : 164 | 19.9994 | 2.5 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| Smrcka et al; Science 251, 15.2.1991, pp804-807 | ||||||||
| 5 | 1345_3pase / ip4_3pase | IP3metabolism Accession No. : 32 | 1345_dephos Pathway No. : 169 | 0.400007 | 0.0012 | 4 | explicit E-S complex | Substrate IP4(1345) Product IP3(145) |
| Ins(1345)P4 3-phosphatase from Nogimori et al, JBC 266; 1991 | ||||||||
IP3(145) acting as a Substrate in a reaction in Osc_Ca_IP3metabolism Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | 3k-CaM*-on | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 80.358 (uM^-1 s^-1) | 180 (s^-1) | Kd(bf) = 2.24(uM) | - | Substrate IP3(145) IP3_3K_CaM* Product cmplx |
| Rates from Km of enzyme Communi et al, EMBO J 16(8) | ||||||||
| 2 | 3k-CaM-on | IP3metabolism Accession No. : 32 | IP3-3K Pathway No. : 162 | 18.7497 (uM^-1 s^-1) | 42.001 (s^-1) | Kd(bf) = 2.2401(uM) | - | Substrate IP3(145) IP3_3K_CaM Product 3kCaM_ip3_cmplx |
| rates from Km for enzyme: Erneux et al, Biochem 214; 1993 Enzyme is 2-2.5 fold more active than ip3-3k, but Km is doubled. | ||||||||
| 3 | 145-inhib-3pase | IP3metabolism Accession No. : 32 | 1345_dephos Pathway No. : 169 | 1 (uM^-1 s^-1) | 1.75 (s^-1) | Kd(bf) = 1.75(uM) | - | Substrate 1345_3pase IP3(145) Product mplx |
| from Hoer et al, Biochem J 270; 1990 | ||||||||
IP3(145) acting as a Product in a reaction in Osc_Ca_IP3metabolism Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | ip3(145)_trp | IP3metabolism Accession No. : 32 | MIPP Pathway No. : 158 | 1 (s^-1) | 0.001 (s^-1) | Not applicable** | - | Substrate IP3(145)_ER Product IP3(145) |
| Ins(145)P3 ER-cytosol transport | ||||||||
| 2 | basal | IP3metabolism Accession No. : 32 | PLCbeta Pathway No. : 164 | 0.003 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate PIP2 Product DAG IP3(145) |
| accounts for other PLC isoforms that contribute to basal levels of IP3 | ||||||||
| 3 | ip4-6pase | IP3metabolism Accession No. : 32 | IP4-system Pathway No. : 167 | 0.013 (s^-1) | 0 (s^-1) | - | - | Substrate IP4(1456) Product IP3(145) |
| this step is essential to maintain flux around the network, rate adjusted accordingly | ||||||||
color.